AGUENNOUZ, M'hammed
 Distribuzione geografica
Continente #
NA - Nord America 9.447
EU - Europa 6.979
AS - Asia 5.486
SA - Sud America 2.357
AF - Africa 212
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
AN - Antartide 1
Totale 24.505
Nazione #
US - Stati Uniti d'America 9.281
SG - Singapore 2.408
BR - Brasile 2.081
IE - Irlanda 1.589
CN - Cina 1.548
SE - Svezia 1.360
IT - Italia 1.137
DE - Germania 830
HK - Hong Kong 674
UA - Ucraina 509
FI - Finlandia 414
VN - Vietnam 317
RU - Federazione Russa 258
GB - Regno Unito 249
FR - Francia 179
PL - Polonia 167
IN - India 128
AR - Argentina 104
CA - Canada 77
BE - Belgio 75
EC - Ecuador 58
MX - Messico 57
ZA - Sudafrica 55
AT - Austria 52
BD - Bangladesh 49
IQ - Iraq 45
TR - Turchia 45
CI - Costa d'Avorio 42
ID - Indonesia 40
MA - Marocco 35
CZ - Repubblica Ceca 33
UZ - Uzbekistan 32
NL - Olanda 31
CO - Colombia 29
JP - Giappone 29
PK - Pakistan 28
VE - Venezuela 28
KE - Kenya 21
ES - Italia 20
PY - Paraguay 19
AZ - Azerbaigian 18
CL - Cile 17
EG - Egitto 16
KZ - Kazakistan 16
TN - Tunisia 14
IR - Iran 13
LT - Lituania 13
NP - Nepal 12
IL - Israele 10
LB - Libano 10
DZ - Algeria 9
UY - Uruguay 9
EU - Europa 8
KG - Kirghizistan 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AU - Australia 7
DO - Repubblica Dominicana 7
BG - Bulgaria 6
JO - Giordania 6
PT - Portogallo 6
SA - Arabia Saudita 6
SN - Senegal 6
CR - Costa Rica 5
GR - Grecia 5
HN - Honduras 5
JM - Giamaica 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
BO - Bolivia 4
CH - Svizzera 4
KH - Cambogia 4
NI - Nicaragua 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
OM - Oman 4
BA - Bosnia-Erzegovina 3
GA - Gabon 3
HR - Croazia 3
KR - Corea 3
LV - Lettonia 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
GT - Guatemala 2
HU - Ungheria 2
KW - Kuwait 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
TH - Thailandia 2
A1 - Anonimo 1
AO - Angola 1
Totale 24.483
Città #
Dublin 1.588
Dallas 1.368
Chandler 1.101
Jacksonville 1.060
Singapore 1.041
Ashburn 952
Nyköping 833
Beijing 692
Hong Kong 674
Messina 356
Princeton 297
Medford 273
Los Angeles 260
The Dalles 255
Munich 251
Ann Arbor 243
Cambridge 243
Des Moines 209
Dearborn 172
São Paulo 155
Warsaw 152
Boardman 128
Buffalo 127
New York 122
Ho Chi Minh City 111
Moscow 92
Helsinki 90
Jinan 82
Wilmington 79
Shenyang 75
Tianjin 68
Brussels 67
San Mateo 66
Turku 66
Rio de Janeiro 64
Woodbridge 63
Redondo Beach 61
Lancaster 60
Belo Horizonte 57
Rome 56
Hanoi 54
Nanjing 48
Hyderabad 46
Bremen 45
Brooklyn 42
Abidjan 41
Curitiba 38
Frankfurt am Main 38
Pune 38
Hebei 36
Vienna 36
Houston 35
Council Bluffs 34
Seattle 34
Brasília 32
Ningbo 31
Porto Alegre 31
Zhengzhou 30
Nuremberg 29
Tokyo 28
Hangzhou 27
Taizhou 27
Tashkent 27
Caltagirone 26
Haikou 26
Johannesburg 26
London 26
Santa Clara 26
Salvador 25
Campinas 24
Dong Ket 24
Norwalk 24
Catania 23
Guarulhos 22
Milan 22
Atlanta 21
Falls Church 21
Montreal 21
Brno 20
Düsseldorf 20
Guayaquil 20
Nairobi 20
Quito 20
Toronto 20
Changsha 19
Ribeirão Preto 19
San Francisco 19
Baku 18
Denver 18
Ottawa 18
Palo Del Colle 18
Phoenix 18
Chicago 17
Guangzhou 17
Nürnberg 17
Osasco 17
Poplar 17
Augusta 16
Baghdad 15
Jakarta 15
Totale 15.291
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 408
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 300
Severe rhabdomyolysis in a patient with “Heat Stroke” 236
Clinical and pathological features of focal myositis 225
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 180
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 178
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 177
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 174
A Nouvel serum MicroRNA signature to screen ATTR 160
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 160
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 157
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 152
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 146
A cytochemical study of apoptosis in metabolic myopathies 145
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 145
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 142
Hippo signaling pathway is altered in Duchenne muscular dystrophy 142
A life threatening case of β-enolase deficiency 141
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 141
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 141
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 135
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 131
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 131
A case of vacuolar myopathy during the course of chronic hepatitis C. 129
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 129
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 129
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 126
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 125
Role of inflammation and oxidative stress mediators in gliomas. 125
A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease 124
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 123
miRNA regulation of Sirtuin-1 expression in human astrocytoma 123
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 123
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 122
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 120
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 120
Analysis of lipid profile in lipid storage myopathy 119
A novel variant of GALC in a familial case of Krabbe disease: Insights from structural bioinformatics and molecular dynamics simulation 118
ANT1 is reduced in sporadic inclusion body myositis. 118
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 116
Effect of exercise on telomere length and telomere proteins expression in mdx mice 115
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 112
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 110
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 110
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 110
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 110
Pilot study of flavocoxid in ambulant DMD patients. 110
Miopatie metaboliche 109
(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis 109
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 108
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 108
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 107
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 107
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 105
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 105
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 105
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 105
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 104
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 103
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 103
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 102
Pilot study of flavocoxid in ambulant DMD patients. 102
A rare PANK2 deletion in the first north African patient affected with pantothenate kinase associated neurodegeneration 102
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 102
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 101
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 101
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 101
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 100
Studio dell'espressione genica del muscolo scheletrico in pazienti affetti da glicogenosi II 99
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 98
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 98
Severe rhabdomyolysis in a patient with “Heat Stroke” 98
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 97
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 95
Sarcoglycans in cerebral cortex of the rat: an immunohistochemical and molecular study. 95
Pilot study of flavocoxid in ambulant DMD patients. 95
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 95
Modulazione della lunghezza telomerica nei diversi gradi di tumore astrogliale nell'uomo. 94
Detection of αII-Spectrin and Breakdown Products in Humans After Severe Traumatic Brain Injury 93
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 93
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 93
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 92
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 92
Fatal R631C mutation is also present in the adult form of CPTII deficiency 92
Meccanismi antiapoptotici NF-kB-mediati in gliomi umani in vivo. 92
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice 91
Calpain 3 deficiency in Quail Eater's disease 91
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 90
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 90
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 89
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 89
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 89
Involvement of Sirt2/HIF-1a pathway in human gliomas with different grade of malignancy 89
Differential expression of Hippo signaling pathway in human astroglial tumors 89
Studio dell'espressione genica della metalloproteinasi 3 e degli inibitori TIMP-1 e TIMP-2 nei meningiomi cerebrali 88
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 88
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 88
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 87
Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies. 87
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 87
Totale 12.045
Categoria #
all - tutte 95.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021919 0 0 0 0 0 154 54 178 88 253 115 77
2021/20221.852 14 232 31 72 96 27 139 83 35 237 238 648
2022/20234.511 372 384 232 323 350 429 72 259 1.914 17 107 52
2023/20241.206 90 188 77 93 122 222 39 79 12 92 27 165
2024/20255.948 108 61 114 335 279 184 149 1.322 1.408 357 608 1.023
2025/20266.011 875 1.240 1.422 1.164 1.204 106 0 0 0 0 0 0
Totale 24.976